Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with BOK, BCL2 family apoptosis regulator (BOK) [47], BAX and BAK are the only BCL2 family members characterized so far in mammalian cells for their ability to form pores across the outer mitochondrial membrane (OMM) and possibly other intracellular membranes [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“which is controlled by pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family, a group of proteins sharing one to four BCL2 homology (BH) domains (i.e., BH1, BH2, BH3, and BH4) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Intrinsic apoptosis is a form of RCD initiated by a variety of microenvironmental perturbations including (but not limited to) growth factor withdrawal, DNA damage, endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) overload, replication stress, microtubular alterations or mitotic defects [29–34].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Thus, most pro-survival BCL2 family members inhibit BAX and BAK by preventing their oligomerization and pore-forming activity either directly, upon physical sequestration at the OMM, or indirectly, following the sequestration of BH3-only activators [29, 64, 79, 110].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Self-citationThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Self-citation
Cited by
Items 501–600 of 1,008
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy
Mohana‐Kumaran, N., Hill, D. S., Allen, J. D., & Haass, N. K. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12242 · Cited by 64
“Some BH3-only proteins have restricted, distinct specificities for antiapoptotic proteins as detailed in Figure 2A (Czabotar et al., 2014).”
BackgroundInfluentialBate-Eya, L. T., den Hartog, I. J. M., van der Ploeg, I., Schild, L. G., Köster, J., Santo, E. E., Westerhout, E. M., Versteeg, R., Caron, H. N., Molenaar, J. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8547 · Cited by 63
“The BCL2 family of proteins are key regulators of the intrinsic apoptotic pathway [2, 3], consisting of anti-apoptotic [e.”
BackgroundWang, M., Li, Y., Ni, C., & Song, G. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480320 · Cited by 63
Liu, Z., Wang, F., Zhou, Z., Xia, H., Wang, X. Y., Yang, Y., He, Z. X., Sun, T., & Zhou, S. F. (2017) · PubMed · Cited by 76
Wang, H., Hu, B., Gao, Z., Zhang, F., & Wang, J. (2020) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2020.02.033 · Cited by 68
Intersection of mitochondrial fission and fusion machinery with apoptotic pathways: Role of Mcl‐1
Morciano, G., Pedriali, G., Sbano, L., Iannitti, T., Giorgi, C., & Pinton, P. (2016) · Biology of the Cell · doi:10.1111/boc.201600019 · Cited by 64
“…optic atrophy 1; PEST, proline (P), glutamic acid (E), serine (S) and threonine (T); TM, transmembrane domain. and Green, 2008; Youle and Strasser, 2008; Chipuk et al., 2010; Llambi and Green, 2011; Shamas-Din et al., 2013; Czabotar et al., 2014; Moldoveanu et al., 2014; Green and Llambi, 2015).”
BackgroundCurrent Understanding of the Structure and Function of Fungal Immunomodulatory Proteins
Liu, Y., Bastiaan‐Net, S., & Wichers, H. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00132 · Cited by 72
Venugopal, S., Shoukier, M., Konopleva, M. Y., Dinardo, C. D., Ravandi, F., Short, N. J., Andreeff, M., Borthakur, G. M., Daver, N. G., Pemmaraju, N., et al. (2021) · Cancer · doi:10.1002/cncr.33675 · Cited by 71
“Apoptosis is a carefully orchestrated programmed cell death network that depends on the interactions between the prosurvival BCL- 2 subfamily proteins (BCL- 2, BCLXL, and MCL1) and BH3- only proapoptotic proteins (PUMA, BID, and BIM).(38) Antiapoptotic protein expression in AML is heterogeneous, and BCL2XL, MCL1- XL,…”
BackgroundHealth benefits of flaxseed and its peptides (linusorbs)
Shim, Y. Y., Kim, J. H., Cho, J. Y., & Reaney, M. J. T. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2119363 · Cited by 70
“Contrary to Bax, B-cell lymphoma 2 (Bcl-2) plays an anti-apoptotic role by inhibiting CytC release (Czabotar et al. 2014).”
BackgroundA Synergistic Dual‐Atom Sites Nanozyme Augments Immunogenic Cell Death for Efficient Immunotherapy
Ning, S., Zhang, Z., Ren, Y., Hou, Y., Li, D., Chen, J., Zhai, Y., Fan, K., & Zhang, W. (2024) · Advanced Science · doi:10.1002/advs.202414734 · Cited by 62
Redefining the BH3 Death Domain as a ‘Short Linear Motif’
Aouacheria, A., Combet, C., Tompa, P., & Hardwick, J. M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.09.007 · Cited by 69
“The BCL-2-regulated apoptotic pathway is a therapeutic target in degenerative disorders, infectious and immune diseases, and cancer [1].”
BackgroundAlhosin, M., León‐González, A. J., Dandache, I., Lelay, A., Rashid, S. K., Kevers, C., Pincemail, J., Fornecker, L., Mauvieux, L., Herbrecht, R., et al. (2015) · Scientific Reports · doi:10.1038/srep08996 · Cited by 62
Moya, A., Sakamaki, K., Mason, B. M., Huisman, L., Forêt, S., Weiss, Y., Bull, T. E., Tomii, K., Imai, K., Hayward, D. C., et al. (2016) · BMC Genomics · doi:10.1186/s12864-015-2355-x · Cited by 65
“A number of Bcl-2 family members, nominally identified as corresponding to Bcl-2 (HO088736; [23]), and the pro-apoptotic proteins Bax (DY581529; [21]) and Bak (EZ037140.”
InfluentialMito-priming as a method to engineer Bcl-2 addiction
Lopez, J., Bessou, M., Riley, J. S., Giampazolias, E., Todt, F., Rochegüe, T., Oberst, A., Green, D. R., Edlich, F., Ichim, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms10538 · Cited by 62
Elkouby, Y. M., & Mullins, M. C. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.06.029 · Cited by 62
“It is possible that Bb degradation precedes other apoptotic phenotypes, such as nucleus degeneration, since the mitochondrial outer membrane provides the platform for initiating apoptosis (Czabotar et al., 2014; Gillies & Kuwana, 2014) and mitochondria are highly enriched in the Bb.”
BackgroundZhu, X., Li, Z., Li, T., Long, F., Lv, Y., Liu, L., Liu, X., & Zhan, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.106 · Cited by 64
The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
Li, Z., Zhang, Y., Chen, L., & Li, H. (2018) · Food & Function · doi:10.1039/c8fo00033f · Cited by 63
Anson, D. M., Wilcox, R. M., Huseman, E. D., Stump, T. A., Paris, R. L., Darkwah, B. O., Lin, S., Adegoke, A. O., Gryka, R. J., Jean‐Louis, D., et al. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13077 · Cited by 64
Aamazadeh, F., Ostadrahimi, A., Saadat, Y. R., & Barar, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05286-w · Cited by 66
Mcl-1 and Bcl-xL sequestration of Bak confers differential resistance to BH3-only proteins
Hockings, C., Alsop, A. E., Fennell, S. C., Lee, E. F., Fairlie, W. D., Dewson, G., & Kluck, R. M. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0010-6 · Cited by 63
Senolytic targets and new strategies for clearing senescent cells
Ge, M., Hu, L., Ao, H.-S., Zi, M., Kong, Q., & He, Y. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111468 · Cited by 67
E3 ligase ligand optimization of Clinical PROTACs
Jiang, H., Xiong, H., Gu, S.-X., & Wang, M. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1098331 · Cited by 68
“BCL-XL belongs to the anti-apoptotic BCL-2 protein family and plays a key role in determining cell life and death by regulating the intrinsic apoptotic pathway (Czabotar et al., 2014).”
BackgroundPANoptosis: Mechanism and Role in Pulmonary Diseases
Chen, S., Jiang, J., Li, T., & Huang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015343 · Cited by 75
“Meanwhile, the intrinsic apoptotic pathway is The loss of integrity of the mitochondrial membrane allows the release of cytochrome c (cyt. mediated by pro-apoptotic Bcl2 family members (BAX, BAK, Bid, etc.) [13].”
BackgroundSørensen, B. H., Nielsen, D., Thorsteinsdottir, U. A., Hoffmann, E. K., & Lambert, I. H. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00256.2015 · Cited by 60
“This cell death process is characterized by sequential net loss of osmolytes (chloride, potassium, amino acids), cell shrinkage [termed apoptotic volume decrease (AVD)], DNA fragmentation, cleavage/activation of executor caspases, and formation of apoptotic bodies, which in our human body is removed by blood-circulati…”
BackgroundDiscovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors
Lee, T., Bian, Z., Zhao, B., Hogdal, L. J., Sensintaffar, J., Goodwin, C. M., Belmar, J., Shaw, S., Tarr, J. C., Veerasamy, N., et al. (2016) · FEBS Letters · doi:10.1002/1873-3468.12497 · Cited by 70
“One of the ways that cancer cells can accomplish this is by up regulating the anti-apoptotic members of the Bcl-2 family of proteins[1, 5, 6].”
BackgroundA candidate for lung cancer treatment: arsenic trioxide
Huang, W., & Zeng, Y. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02054-6 · Cited by 61
Gilbert, R. J. C. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.026 · Cited by 69
“Incomplete rings or non-ring-shaped structures such as those formed by membrane attack complex-perforin/cholesterol-dependent cytolysin (MACPF/CDC) family proteins and Bax-like proteins have a more obvious direct role for lipids in pore structure [7, 12, 14, 21-23]; but even where complete rings of subunits form, lipi…”
BackgroundP53 enhances apoptosis induced by doxorubicin only under conditions of severe DNA damage
Lin, R., Ho, C.-J., Chen, H.-W., Pao, Y., Chen, L.-E., Yang, M.-C., Huang, S., Wang, S., Chen, C., & Wang, C. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1520565 · Cited by 62
“Instead of DNA repair, they and other BH3-only proteins are responsible for initiating the apoptosis pathway [9,10].”
BackgroundSabitha, R., Nishi, K., Gunasekaran, V. P., Balupillai, A., David, E. K., Govindhan, A., Rajamanickam, V., Malliga, P., Latha, S., & Ganeshan, M. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109044 · Cited by 65
Cellular and developmental basis of orofacial clefts
Ji, Y., Garland, M. A., Sun, B. H., Zhang, S., Reynolds, K., McMahon, M. M., Rajakumar, R., Islam, M. S., Liu, Y., Chen, Y., et al. (2020) · Birth Defects Research · doi:10.1002/bdr2.1768 · Cited by 74
Review of microRNA in osteosarcoma and chondrosarcoma
Chang, L., Shrestha, S., LaChaud, G., Scott, M., & James, A. W. (2015) · Medical Oncology · doi:10.1007/s12032-015-0613-z · Cited by 61
Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury
Nakamura, M., Zhai, P., Re, D. P. D., Maejima, Y., & Sadoshima, J. (2016) · JCI Insight · doi:10.1172/jci.insight.86217 · Cited by 60
“Increased oligomerization of Bax within the mitochondrial outer membrane promotes cytochrome c release into the cytosol (20).”
Maeda, Y., Takahashi, H., Nakai, N., Yanagita, T., Ando, N., Okubo, T., Saito, K., Shiga, K., Hirokawa, T., Hara, M., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4308 · Cited by 65
“The over-expression of anti-apoptotic Bcl-2 family proteins, including Bcl-xL and Mcl-1, is observed in different types of human cancer and this overexpression is involved in the development of resistance to treatments such as chemotherapy, as well as in cell survival (32,33).”
Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins
de Araujo, A. D., Lim, J., Wu, K., Xiang, Y., Good, A. C., Skerlj, R. T., & Fairlie, D. P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00010 · Cited by 62
Targeting apoptosis pathways in infections
Naderer, T., & Fulcher, M. C. (2018) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0717-286r · Cited by 66
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
Ariës, I. M., Bodaar, K., Karim, S., Chonghaile, T. N., Hinze, L., Burns, M., Pfirrmann, M., Degar, J., Landrigan, J., Balbach, S. T., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180570 · Cited by 61
“…available material (Tables S1 and S3–S6) The best-known regulators of mitochondrial apoptosis are genes of the BCL2 family (Davids and Letai, 2012; Czabotar et al., 2014), but RNA-seq revealed no difference in expression of any of the known pro- or antiapoptotic BCL2 family genes between…”
BackgroundMolecular Chaperone HSP70 and Key Regulators of Apoptosis - A Review
Roufayel, R., & Kadry, S. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190326114720 · Cited by 64
Yue, R., Chen, M., & Ma, N. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09494 · Cited by 63
Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
Lee, J.-H., Mellado‐Gil, J. M., Bahn, Y. J., Pathy, S. M., Zhang, Y. E., & Rane, S. G. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2365-8 · Cited by 67
Targeting ferroptosis in gastric cancer: Strategies and opportunities
Le, J., Pan, G., Zhang, C., Chen, Y., Tiwari, A. K., & Qin, J. (2023) · Immunological Reviews · doi:10.1111/imr.13280 · Cited by 68
Vikström, I. B., Slomp, A., Carrington, E. M., Moesbergen, L. M., Chang, C., Kelly, G. L., Glaser, S. P., Jansen, J. H. M., Leusen, J. H. W., Strasser, A., et al. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.237 · Cited by 59
“BCL-2, BCL-XL, BCL-W, A1 and MCL-1, are capable of inhibiting the mitochondrial apoptotic pathway.(1) Transgenic expres-”
Self-citationMdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells
Feeley, K. P., Adams, C. M., Mitra, R., & Eischen, C. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0809 · Cited by 63
Cell cycle arrest in mitosis promotes interferon-induced necroptosis
Frank, T., Tuppi, M., Hugle, M., Dötsch, V., van Wijk, S. J. L., & Fulda, S. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0298-5 · Cited by 64
Delbridge, A. R. D., Kueh, A. J., Ke, F., Zamudio, N., El-Saafin, F., Jansz, N., Wang, G., Iminitoff, M., Beck, T. J., Haupt, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.048 · Cited by 69
Self-citationDai, H., Ding, H., Meng, X. W., Peterson, K. L., Schneider, P. A., Karp, J. E., & Kaufmann, S. H. (2015) · Genes & Development · doi:10.1101/gad.267997.115 · Cited by 68
“According to one model, their activation is triggered when cellular stresses lead to increased expression or activity of BH3-only members of the BCL2 family, such as BIM, PUMA, or BID (Chipuk and Green 2008; Strasser et al. 2011; Czabotar et al. 2014).”
Poxviral Strategies to Overcome Host Cell Apoptosis
Suraweera, C. D., Hinds, M. G., & Kvansakul, M. (2020) · Pathogens · doi:10.3390/pathogens10010006 · Cited by 61
“Other roles have also been ascribed to the Bcl-2 proteins including autophagy [31,32] and cytosolic Ca2+ regulation [33].”
BackgroundGuo, Q., Kawahata, K., Cheng, A., Wang, H., Jia, W., Yoshino, H., & Fukunaga, K. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102547 · Cited by 65
NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT
Nakshatri, H., Appaiah, H. N., Anjanappa, M., Gilley, D. P., Tanaka, H., Badve, S., Crooks, P. A., Mathews, W. P., Sweeney, C. J., & Bhat‐Nakshatri, P. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.569 · Cited by 61
“BIM polymorphism and BIM levels in treatment-naive cancers determine sensitivity to receptor kinase inhibitors, particularly EGFR and mutant B-RAF signaling pathway inhibitors, glucocorticoids, and paclitaxel.(48) NSD1 methylates and activates non-histone targets, including the p65 subunit of NF-κB.”
BackgroundIdentification of an activation site in Bak and mitochondrial Bax triggered by antibodies
Iyer, S., Anwari, K., Alsop, A. E., Yuen, W. S., Huang, D. C. S., Carroll, J., Smith, N. A., Smith, B. J., Dewson, G., & Kluck, R. M. (2016) · Nature Communications · doi:10.1038/ncomms11734 · Cited by 58
Shen, W., Wang, H., Ling-hu, Y., Lv, J., Chang, H., & Cheng, Y. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01929c · Cited by 58
Marcu, R., Zheng, Y. Y., & Hawkins, B. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_21 · Cited by 61
Serikawa, T., Spanos, C., von Hacht, A., Budiša, N., Rappsilber, J., & Kurreck, J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.11.003 · Cited by 58
Rodríguez‐Fernández, J. L., & Criado‐García, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00528 · Cited by 65
Xia, X., Liao, Y., Guo, Z., Li, Y., Jiang, L., Zhang, F., Huang, C., Liu, Y., Wang, X., Liu, N., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0086-y · Cited by 57
Competing endogenous RNAs in lung cancer
Zhao, M., Feng, J., & Tang, L. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0203 · Cited by 62
Mitochondrial Oxidative Stress and Cell Death in Podocytopathies
Zhu, Y., Wan, C., Lin, J., Hammes, H., & Zhang, C. (2022) · Biomolecules · doi:10.3390/biom12030403 · Cited by 64
“However, pro-survival members of the BCL2 protein family, such as BCL2 and BCL2-like 1 (BCL2L1), can antagonize MOMP to inhibit the occurrence of apoptosis [14,98].”
BackgroundLi, R.-Y., Zheng, Z.-Y., Li, Z., Heng, J.-H., Zheng, Y.-Q., Deng, D.-X., Xu, X., Liao, L., Lin, W., Xu, H.-Y., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109967 · Cited by 59
Dissociation of Bak α1 helix from the core and latch domains is required for apoptosis
Alsop, A. E., Fennell, S. C., Bartolo, R. C., Tan, I. K. L., Dewson, G., & Kluck, R. M. (2015) · Nature Communications · doi:10.1038/ncomms7841 · Cited by 57
“Bak a1 (24–50) 14–36 26–36 P Rabbit Unknown 1:2,000– 1:3,000 1:2,000 (1) 1:3,000 (2) 14–36 BD 556396 42”
InfluentialSun, S., Yang, S., Dai, M., Jia, X., Wang, Q., Zhang, Z., & Mao, Y. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1828-7 · Cited by 57
“The pro-apoptotic family member Bax can undergo conformational change, and translocate from cytoplasm to the mitochondria when activated [44].”
BackgroundRicucci, D., Loghin, S., Niu, L., & Tay, F. R. (2018) · Journal of Dentistry · doi:10.1016/j.jdent.2018.04.007 · Cited by 60
Intrinsic Instability of BOK Enables Membrane Permeabilization in Apoptosis
Zheng, J. H., Grace, C. R., Guibao, C. D., McNamara, D. E., Llambi, F., Wang, Y., Chen, T., & Moldoveanu, T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.060 · Cited by 63
“MOMP is executed by the effector BCL-2 family proteins BCL-2 antagonist killer (BAK), BCL-2-associated × protein (BAX), and BCL-2 ovarian killer (BOK) (Czabotar et al., 2014; Llambi et al., 2016; Moldoveanu et al., 2014).”
BackgroundProtocatechuic acid inhibits the growth of ovarian cancer cells by inducing apoptosis and autophagy
Xie, Z., Guo, Z., Wang, Y., Lei, J., & Yu, J. J. (2018) · Phytotherapy Research · doi:10.1002/ptr.6163 · Cited by 57
Kowsalya, E., MosaChristas, K., Jaquline, C. R. I., Balashanmugam, P., & Devasena, T. (2020) · Applied Organometallic Chemistry · doi:10.1002/aoc.6071 · Cited by 60
Cell death in skin function, inflammation, and disease
Anderton, H., & Alqudah, S. (2022) · Biochemical Journal · doi:10.1042/bcj20210606 · Cited by 67
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 64
MarsGT: Multi-omics analysis for rare population inference using single-cell graph transformer
Wang, X., Duan, M., Li, J., Ma, A., Xin, G., Xu, D. H., Li, Z., Liu, B., & Ma, Q. (2024) · Nature Communications · doi:10.1038/s41467-023-44570-8 · Cited by 62
Su, B.-H., Qu, J., Song, M. S., Huang, X., Hu, X.-M., Xie, J. W., Zhao, Y., Ding, L.-C., She, L., Chen, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2321 · Cited by 57
“Among these validated target genes, BCL-2 is a well-known anti-apoptotic gene [26], and CCND1 is a cell cycle-related gene [27], consistent with the increased apoptotic cells (Fig.”
The Role of BCL-2 Family Members in Acute Kidney Injury
Borkan, S. C. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.04.001 · Cited by 58
Diosgenin-induced autophagy and apoptosis in a human prostate cancer cell line
Nie, C., Zhou, J., Qin, X., Shi, X., Zeng, Q., Liu, J., Yan, S., & Zhang, L. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5750 · Cited by 61
“Bcl2 inhibits apoptosis (62) and interacts with Beclin 1.”
BackgroundKang, X.-H., Zhang, J.-H., Zhang, Q.-Q., Cui, Y.-H., Wang, Y., Kou, W.-Z., Miao, Z.-H., Lu, P., Wang, L.-F., Xu, Z.-Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475438 · Cited by 55
Mcl-1 and Bcl-xL are essential for survival of the developing nervous system
Fogarty, L. C., Flemmer, R. T., Geizer, B. A., Licursi, M., Karunanithy, A., Opferman, J. T., Hirasawa, K., & Vanderluit, J. L. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0225-1 · Cited by 62
Dengler, M. A., Robin, A. Y., Gibson, L., Li, X., Sandow, J. J., Iyer, S., Webb, A. I., Westphal, D., Dewson, G., & Adams, J. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.040 · Cited by 60
Self-citationRegulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents
Whitaker, R. H., & Placzek, W. J. (2019) · Cells · doi:10.3390/cells8040346 · Cited by 62
“prevailing models (direct and indirect) were proposed to describe the impact that BH3-only proteins utilize to regulate the BCL2 family [53,63].”
BackgroundPourhanifeh, M., Shafabakhsh, R., Reiter, R., & Asemi, Z. (2019) · Current pharmaceutical design · doi:10.2174/1381612825666190717110932 · Cited by 48
Eckol Inhibits Particulate Matter 2.5-Induced Skin Keratinocyte Damage via MAPK Signaling Pathway
Zhen, A. X., Hyun, Y. J., Piao, M. J., Fernando, P. D. S. M., Kang, K. A., Ahn, M. J., Yi, J. M., Kang, H. K., Koh, Y. S., Lee, N. H., et al. (2019) · Marine Drugs · doi:10.3390/md17080444 · Cited by 58
“Bcl-2 plays an anti-apoptotic role, whereas Bax is proapoptotic [37].”
BackgroundMunakarmi, S., Chand, L., Shin, H. B., Jang, K. Y., & Jeong, Y. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062048 · Cited by 56
Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis
Wang, H., Ge, C., Zhou, J., Guo, Y., Cui, S., Huang, N., Yan, T., Cao, L., Che, Y., Zheng, Q., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.028 · Cited by 55
Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis
Karlowitz, R., & van Wijk, S. J. L. (2021) · FEBS Journal · doi:10.1111/febs.16255 · Cited by 62
Enhancing the Theranostic Performance of Organic Photosensitizers with Aggregation-Induced Emission
Kenry, K., & Liu, B. (2022) · Accounts of Materials Research · doi:10.1021/accountsmr.2c00039 · Cited by 55
Shehata, M. K., Ismail, A. A., & Kamel, M. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417928 · Cited by 55
“178,179 GSK-3β stimulates apoptosis by increasing the pro-apoptotic cytokines and decreasing the anti-apoptotic cytokines.”
BackgroundQi, M., Wang, D., Wang, Q., Zhang, Z., Ao, Y., Li, J., & Huang, S. (2024) · Advanced Materials · doi:10.1002/adma.202412191 · Cited by 63
Richardson, J. S. M., Sethi, G., Lee, G. S., & Malek, S. N. A. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1368-6 · Cited by 58
“The balance of function between proapoptotic and antiapoptotic BCL-2 protein family determines the fate of cells towards apoptosis [15].”
BackgroundDeng, Y., Long, L., Wang, K., Zhou, J., Zeng, L., He, L., & Gong, Q. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00039 · Cited by 57
Feng, C., Luo, Y., Nian, Y., Liu, D., Yin, X., Wu, J., Di, J., Zhang, R., & Zhang, J. (2017) · Inflammation · doi:10.1007/s10753-017-0526-4 · Cited by 55
Deyu, H., Cui, L., Xianglian, L., Guo, P., Lu, Q., Wang, X., & Zonghui, Y. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.05.041 · Cited by 61
Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth
Fults, D. W., Taylor, M. D., & Garzia, L. (2019) · Journal of Neurosurgery Pediatrics · doi:10.3171/2018.11.peds18506 · Cited by 70
Li, Z., Mbah, N. E., Overmeyer, J. H., Sarver, J. G., George, S., Trabbic, C. J., Erhardt, P., & Maltese, W. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-5288-y · Cited by 59
“proteins like Bax, facilitating outer mitochondrial membrane pore formation and release of cytochrome c [62]; 2) alteration of Bcl-2 function in the endoplasmic reticulum, causing discharge of Ca, with consequential mitochondrial calcium overload [63]; 3) release of Beclin-1 from inhibitory Beclin-1/Bcl-2 complexes, c…”
BackgroundQin, Q., Wang, Z., Wang, S., Luo, D.-M., Zou, B., Yao, P.-F., Tan, M., & Liang, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.014 · Cited by 54
Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives
Fleischmann, M., Schnetzke, U., Hochhaus, A., & Scholl, S. (2021) · Cancers · doi:10.3390/cancers13225722 · Cited by 69
“Downregulation of BCL-2 reduces venetoclax sensitivity as well as reduced activation of mitochondrial apoptosis effectors BAX and BAK.”
BackgroundInfluentialmiR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity
Fujiwara, N., Inoue, J., Kawano, T., Tanimoto, K., Kozaki, K., & Inazawa, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0257 · Cited by 58
“Augmentation of chemotherapy-induced cytotoxicity by miR-634 Because the cytotoxicity of cancer drugs such as cisplatin (CDDP) and 5-FU is closely associated with the mitochondrial apoptosis pathway (11, 25, 26), we speculated that combined treatment with enforced expression of miR-634 may be able to effectively enhan…”
BackgroundBrady, S. W., Zhang, J., Tsai, M.-H., & Yu, D. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1002693 · Cited by 56
“It is regulated by the Bcl2 family of proteins, which act on upstream cellular signals (such as the PI3K and MAPK pathways, which activate pro-survival Bcl2 family proteins to suppress cytochrome C release(25) or inhibit activation of pro-death Bcl2 family proteins(26,27)) to combinatorially determine whether to allow…”
BackgroundZhang, L., Fang, Y., Xu, X., & Jin, D. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6144 · Cited by 54
“Anti-apoptotic members, such as Bcl2, prevent apoptosis, whereas proapoptotic members, such as Bax and Bak, reside on the outer mitochondrial membrane or cytosol and oligo-merize under stress to facilitate the release of factors from the mitochondria, which trigger apoptosis (29).”
A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer
Coppola, S., Carnevale, I., Danen, E. H. J., Peters, G. J., Schmidt, T., Assaraf, Y. G., & Giovannetti, E. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.07.001 · Cited by 56
Ghaemi, B., Shaabani, E., Najafi-Taher, R., Nodooshan, S. J., Sadeghpour, A., Kharrazi, S., & Amani, A. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b03822 · Cited by 55
Zou, Y., Lei, W., Su, S., Bu, J., Zhu, S., Huang, Q., & Li, Z. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3422-9 · Cited by 58
“The anti-apoptotic Bcl-2 proteins can antagonize Bax/Bak activation and thereby inhibit apoptosis [7, 8].”
BackgroundWang, L., Xu, J., Yan, Y., Liu, H., & Li, F. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1593852 · Cited by 54
“Apoptosis is a crucial controller of tissue homeostasis [41,42].”
BackgroundMasamsetti, V. P., Low, R. R. J., Mak, K. S., O’Connor, A., Riffkin, C. D., Lamm, N., Crabbé, L., Karlseder, J., Huang, D. C. S., Hayashi, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12255-w · Cited by 56
Vandghanooni, S., Eskandani, M., Barar, J., & Omidi, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118729 · Cited by 59
Hauseman, Z. J., Harvey, E. P., Newman, C. E., Wales, T. E., Bucci, J. C., Mintseris, J., Schweppe, D. K., David, L., Fan, L., Cohen, D. T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.029 · Cited by 65
“Deregulation of apoptosis gives rise to a host of human diseases characterized by cellular excess or premature cell demise (Czabotar et al., 2014).”
BackgroundSelective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy
Akhtar, M. J., Alhadlaq, H. A., Kumar, S., Alrokayan, S., & Ahamed, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1570-1 · Cited by 56
Metadata
- Authors
- Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Strasser, Andreas
- Adams, Jerry M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2013-12-20
- Volume
- 15
- Issue
- 1
- Pages
- 49-63
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2088883749
- Cited by
- 3,219
- References
- 218
- Citations by year
- 2026: 164 · 2025: 220 · 2024: 249 · 2023: 230 · 2022: 265 · 2021: 319 · 2020: 299 · 2019: 285 · 2018: 314 · 2017: 292 · 2016: 287 · 2015: 209 · 2014: 77 · 2013: 1
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2 family proteins, apoptosis, mitochondrial outer membrane, BCL-2 inhibitor, cancer therapy, autoimmune disease, neurodegeneration, ischemia, apoptosis regulation
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Sequence Data, Neoplasms, Signal Transduction, Apoptosis, Protein Structure, Secondary, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Protein Multimerization, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.